113 related articles for article (PubMed ID: 28983945)
21. Evaluation of DNA methylation at imprinted DMRs in the spermatozoa of oligozoospermic men in association with MTHFR C677T genotype.
Louie K; Minor A; Ng R; Poon K; Chow V; Ma S
Andrology; 2016 Sep; 4(5):825-31. PubMed ID: 27369467
[TBL] [Abstract][Full Text] [Related]
22. SPATA16 promoter hypermethylation and downregulation in male infertility.
Sujit KM; Pallavi S; Singh V; Andrabi SW; Trivedi S; Sankhwar SN; Gupta G; Rajender S
Andrologia; 2022 Nov; 54(10):e14548. PubMed ID: 36177775
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
[TBL] [Abstract][Full Text] [Related]
24. "Null pattern" of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation.
Hagen CE; Lefferts J; Hornick JL; Srivastava A
Am J Surg Pathol; 2011 Dec; 35(12):1902-5. PubMed ID: 22067334
[TBL] [Abstract][Full Text] [Related]
25. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I-II colon cancer patients.
Huang SC; Huang SF; Chen YT; Chang Y; Chiu YT; Chang IC; Wu HI; Chen JS
Biomed J; 2017 Feb; 40(1):39-48. PubMed ID: 28411881
[TBL] [Abstract][Full Text] [Related]
27. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
28. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
29. Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
Wojtczyk-Miaskowska A; Presler M; Michajlowski J; Matuszewski M; Schlichtholz B
Cell Physiol Biochem; 2017; 42(6):2404-2417. PubMed ID: 28848075
[TBL] [Abstract][Full Text] [Related]
30. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract][Full Text] [Related]
31. Exonic deletions of mismatch repair genes MLH1 and MSH2 correlate with prognosis and protein expression levels in malignant melanomas.
Korabiowska M; Brinck U; Stachura J; Jawien J; Hasse FM; Cordon-Cardos C; Fischer G
Anticancer Res; 2006; 26(2A):1231-5. PubMed ID: 16619529
[TBL] [Abstract][Full Text] [Related]
32. The sperm epigenome does not display recurrent epimutations in patients with severely impaired spermatogenesis.
Leitão E; Di Persio S; Laurentino S; Wöste M; Dugas M; Kliesch S; Neuhaus N; Horsthemke B
Clin Epigenetics; 2020 May; 12(1):61. PubMed ID: 32375885
[TBL] [Abstract][Full Text] [Related]
33. Prediction of MLH1 and MSH2 mutations in Lynch syndrome.
Balmaña J; Stockwell DH; Steyerberg EW; Stoffel EM; Deffenbaugh AM; Reid JE; Ward B; Scholl T; Hendrickson B; Tazelaar J; Burbidge LA; Syngal S
JAMA; 2006 Sep; 296(12):1469-78. PubMed ID: 17003395
[TBL] [Abstract][Full Text] [Related]
34. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
[TBL] [Abstract][Full Text] [Related]
35. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
[TBL] [Abstract][Full Text] [Related]
36. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
Deihimi S; Lev A; Slifker M; Shagisultanova E; Xu Q; Jung K; Vijayvergia N; Ross EA; Xiu J; Swensen J; Gatalica Z; Andrake M; Dunbrack RL; El-Deiry WS
Oncotarget; 2017 Jun; 8(25):39945-39962. PubMed ID: 28591715
[TBL] [Abstract][Full Text] [Related]
37. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
38. Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family.
Cini G; Carnevali I; Quaia M; Chiaravalli AM; Sala P; Giacomini E; Maestro R; Tibiletti MG; Viel A
Carcinogenesis; 2015 Apr; 36(4):452-8. PubMed ID: 25742745
[TBL] [Abstract][Full Text] [Related]
39. A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma.
Li Q; Hong J; Shen Z; Deng H; Shen Y; Wu Z; Zhou C
Medicine (Baltimore); 2019 Oct; 98(43):e17651. PubMed ID: 31651887
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer.
V S; Bhagat R; C S P; V R P; Krishnamoorthy L
Genomics; 2014 Oct; 104(4):257-63. PubMed ID: 25192888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]